Have you ever wondered if you're getting the most out of genomic testing for prostate cancer?
In this animated video, GU cancer genomics expert Dr Alexander Wyatt shares the guideline recommendations and best tips for precision oncology in prostate cancer.
Multi-gene germline and somatic testing is required for the identification of gene alterations in advanced prostate cancer. Both tissue and liquid biopsy (ctDNA) can be used for somatic testing, but it’s important for HCPs to know when to use liquid biopsy and how to conserve the quality of tissue samples.
Dr Wyatt addresses these questions and highlights other key points, including:
- Common genomic alterations and implications in prostate cancer
- When to order biomarker testing
- Samples that can be used for somatic and germline testing
- Potential challenges and recommendations to reduce the limitations of testing and interpreting results
Find out more about the programme and see Dr Wyatt's key clinical takeaways: [ Ссылка ]
Follow PRECISION ONCOLOGY CONNECT on social media:
X: [ Ссылка ]
LinkedIn: [ Ссылка ]
Published September 2024.
This content is intended for healthcare professionals only.
The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Medical Education Grant from AstraZeneca and Amoy Diagnostics.
This video is developed by [ Ссылка ]
